| Metric | შპს ტლ მედიკალ | შპს მედლაბ 2024 | შპს ქრომოსი |
|---|---|---|---|
| Growth | |||
| Revenue | ₾1.8m | ₾1.8m | ₾1.8m |
| Revenue growth | — | — | — |
| Profitability | |||
| EBITDA | ₾218k | ₾582k | ₾525k |
| EBITDA margin | 12.3% | 33.0% | 28.5% |
| Net profit | ₾209k | ₾586k | ₾537k |
| Net margin | 11.8% | 33.2% | 29.1% |
| Balance sheet | |||
| Total assets | ₾2.3m | ₾1.3m | ₾2.2m |
| Total equity | ₾1.1m | ₾586k | ₾50k |
| ROE | 18.7% | 100.0% | 1067.0% |